Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Maurer

Showing results (11-20 of 658) with videos related to

Pageof 66
Sort By:
The Journal of Investigative Dermatology|June 12, 2009
Desloratadine inhibits human skin mast cell activation and histamine releaseKarsten Weller, Marcus Maurer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 7, 2010
Hereditary angioedema: an update on available therapeutic optionsMarcus Maurer, Markus Magerl
Allergologie Select|February 22, 2021
Use of biologics in chronic spontaneous urticaria - beyond omalizumab therapy?Martin Metz, Marcus Maurer
The Journal of Allergy and Clinical Immunology. in Practice|June 11, 2021
The Road to Better Urticaria and Angioedema ManagementMarc Riedl, Marcus Maurer
Expert Review of Clinical Immunology|January 9, 2015
Omalizumab for the treatment of chronic urticariaTorsten Zuberbier, Marcus Maurer
Immunological Reviews|February 13, 2018
What we know (and don't know) about the biology and functions of mast cells and basophilsMarcus Maurer, Carlo Pucillo
Experimental Dermatology|November 9, 2005
The status quo and quo vadis of mast cellsMarcus Maurer, Martin Metz
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2024
Acute urticaria management: Gaps, challenges and the need for further evidenceEmek Kocatürk, Marcus Maurer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2010
Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternativesMarcus Maurer, Markus Magerl
Expert Review of Clinical Immunology|December 18, 2010
Rupatadine for the treatment of allergic rhinitis and urticariaMartin Metz, Marcus Maurer
Pageof 66

Showing results (11-20 of 658) with videos related to

Sort By:
Pageof 66
The Journal of Investigative Dermatology|June 12, 2009
Desloratadine inhibits human skin mast cell activation and histamine releaseKarsten Weller, Marcus Maurer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 7, 2010
Hereditary angioedema: an update on available therapeutic optionsMarcus Maurer, Markus Magerl
Allergologie Select|February 22, 2021
Use of biologics in chronic spontaneous urticaria - beyond omalizumab therapy?Martin Metz, Marcus Maurer
The Journal of Allergy and Clinical Immunology. in Practice|June 11, 2021
The Road to Better Urticaria and Angioedema ManagementMarc Riedl, Marcus Maurer
Expert Review of Clinical Immunology|January 9, 2015
Omalizumab for the treatment of chronic urticariaTorsten Zuberbier, Marcus Maurer
Immunological Reviews|February 13, 2018
What we know (and don't know) about the biology and functions of mast cells and basophilsMarcus Maurer, Carlo Pucillo
Experimental Dermatology|November 9, 2005
The status quo and quo vadis of mast cellsMarcus Maurer, Martin Metz
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2024
Acute urticaria management: Gaps, challenges and the need for further evidenceEmek Kocatürk, Marcus Maurer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2010
Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternativesMarcus Maurer, Markus Magerl
Expert Review of Clinical Immunology|December 18, 2010
Rupatadine for the treatment of allergic rhinitis and urticariaMartin Metz, Marcus Maurer
Pageof 66